OMCL - Omnicell, Inc.
IEX Last Trade
44.505
-0.755 -1.696%
Share volume: 281,169
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.56%
PREVIOUS CLOSE
CHG
CHG%
$45.26
-0.76
-1.67%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-09 | 2022-11-04 | 2023-03-01 | 2023-05-05 | 2023-08-04 | 2023-11-03 | 2024-02-28 | 2024-05-07 | |
| Assets | |||||||||
| Total Assets | 2.131 B | 2.180 B | 2.211 B | 2.251 B | 2.194 B | 2.222 B | 2.227 B | 2.284 B | |
| Current Assets | 787.770 M | 849.132 M | 881.812 M | 934.969 M | 881.361 M | 913.751 M | 927.571 M | 989.918 M | |
| Inventories | 150.461 M | 147.096 M | 147.549 M | 141.156 M | 130.577 M | 116.144 M | 110.099 M | 103.466 M | |
| Other Current Assets | 50.696 M | 46.287 M | 47.729 M | 48.155 M | 42.992 M | 47.216 M | 53.826 M | 69.004 M | |
| Short Term Investments | 50.696 M | 46.287 M | 47.729 M | 48.155 M | 42.992 M | 47.216 M | 53.826 M | 69.004 M | |
| Total Receivables | 310.520 M | 354.098 M | 299.469 M | 322.073 M | 273.899 M | 272.584 M | 252.025 M | 248.512 M | |
| Current Cash | 244.953 M | 266.402 M | 330.362 M | 340.413 M | 399.464 M | 446.840 M | 467.972 M | 512.364 M | |
| Total Non-current Assets | 1.344 B | 1.331 B | 1.329 B | 1.316 B | 1.313 B | 1.308 B | 1.299 B | 1.294 B | |
| Property Plant Equipment | 81.834 M | 88.356 M | 93.961 M | 98.373 M | 103.212 M | 106.880 M | 108.601 M | 109.034 M | |
| Other Assets | 115.486 M | 113.961 M | 116.664 M | 113.008 M | 113.482 M | 116.475 M | 119.175 M | 116.877 M | |
| Intangible Assets | 349.507 M | 336.190 M | 323.666 M | 311.803 M | 299.832 M | 288.733 M | 277.832 M | 268.655 M | |
| Goodwill | 734.487 M | 731.294 M | 734.274 M | 734.895 M | 735.523 M | 734.328 M | 735.810 M | 735.357 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.131 B | 2.180 B | 2.211 B | 2.251 B | 2.194 B | 2.222 B | 2.227 B | 2.284 B | |
| Total liabilities | 1.039 B | 1.044 B | 1.081 B | 1.108 B | 1.030 B | 1.034 B | 1.038 B | 1.095 B | |
| Total current liabilities | 373.514 M | 376.681 M | 428.446 M | 453.968 M | 370.157 M | 369.361 M | 367.792 M | 416.364 M | |
| Accounts Payable | 68.400 M | 73.517 M | 63.389 M | 63.407 M | 47.192 M | 49.920 M | 45.028 M | 43.145 M | |
| Other liabilities | 32.995 M | 43.804 M | 44.104 M | 48.574 M | 55.015 M | 61.481 M | 64.940 M | 72.294 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 565.035 M | 565.803 M | 566.571 M | 567.342 M | 568.114 M | 568.887 M | 569.662 M | 570.439 M | |
| Other liabilities | 32.995 M | 43.804 M | 44.104 M | 48.574 M | 55.015 M | 61.481 M | 64.940 M | 72.294 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.093 B | 1.135 B | 1.130 B | 1.143 B | 1.164 B | 1.187 B | 1.189 B | 1.189 B | |
| Common stock | 44.219 M | 44.441 M | 44.683 M | 44.887 M | 45.125 M | 45.333 M | 45.503 M | 45.732 M | |
| Retained earnings | 402.362 M | 419.136 M | 390.728 M | 375.728 M | 379.179 M | 384.732 M | 370.357 M | 354.681 M |